Mainstreaming Addiction Treatment Act of 2021 [S.445]
A bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.
S.445: Mainstreaming Addiction Treatment Act of 2021
Sponsored by: Sen. Robert Casey
Referred To The Committee On Health, Education, Labor, And Pensions. on 02/25/2021
FDA Modernization Act 2.0 [S.5002]
A bill to allow for alternatives to animal testing for purposes of drug and biological product applications.
S.5002: FDA Modernization Act 2.0
Sponsored by: Sen. Susan Collins
Introduced In The Senate, Read Twice, Considered, Read The Third Time, And Passed Without Amendment By Unanimous Consent. on 09/29/2022
NEPA Accountability and Enforcement Act [S.721]
A bill to amend the National Environmental Policy Act of 1969 to impose time limits on the completion of certain required actions under the Act, and for other purposes.
S.721: NEPA Accountability and Enforcement Act
Sponsored by: Sen. Mike Lee
Read Twice And Referred To The Committee On Environment And Public Works. on 03/11/2021
Supply Chain Disruptions Relief Act [S.4105]
A bill to treat certain liquidations of new motor vehicle inventory as qualified liquidations of LIFO inventory for purposes of the Internal Revenue Code of 1986.
S.4105: Supply Chain Disruptions Relief Act
Sponsored by: Sen. Robert Casey
Received In The House. on 12/23/2022
Journalism Competition and Preservation Act of 2022 [S.673]
A bill to provide a temporary safe harbor for publishers of online content to collectively negotiate with dominant online platforms regarding the terms on which content may be distributed.
S.673: Journalism Competition and Preservation Act of 2022
Sponsored by: Sen. Susan Collins
Committee On The Judiciary. Reported By Senator Durbin With An Amendment In The Nature Of A Substitute. Without Written Report. on 11/28/2022
Breakthrough Therapies Act [S.5123]
A bill to amend the Controlled Substances Act to modify the registration requirements relating to research, and for other purposes.
S.5123: Breakthrough Therapies Act
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On The Judiciary. on 11/17/2022